Clinical Trial Update: Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne [Phase 2]

View source ↗

Summary

Phase 2 exploratory study assessing the efficacy and safety of CD07223 Gel in acne patients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne

Drugs mentioned

• CD07223 Gel

Snippet

Sponsor: Galderma R&D | Conditions: Acne | Phase 2 | Status: COMPLETED